Results
|
1701.
|
|
|
1702.
|
|
|
1703.
|
|
|
1704.
|
|
|
1705.
|
|
|
1706.
|
|
|
1707.
|
|
|
1708.
|
|
|
1709.
|
|
|
1710.
|
|
|
1711.
|
Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas. [electronic resource] by
- von Minckwitz, Gunter
- Harder, Sebastian
- Hövelmann, Sascha
- Jäger, Elke
- Al-Batran, Salah-Eddin
- Loibl, Sibylle
- Atmaca, Akin
- Cimpoiasu, Christian
- Neumann, Antje
- Abera, Aklil
- Knuth, Alexander
- Kaufmann, Manfred
- Jäger, Dirk
- Maurer, Alexander B
- Wels, Winfried S
Producer: 20060223
In:
Breast cancer research : BCR vol. 7
Availability: No items available.
|
|
1712.
|
|
|
1713.
|
|
|
1714.
|
|
|
1715.
|
|
|
1716.
|
|
|
1717.
|
|
|
1718.
|
|
|
1719.
|
|
|
1720.
|
|